Solana treasury company Artelo Biosciences completes a $3 million share allocation
Source: ForesightNews
Time: 2025-09-09 16:26:57
Artelo Biosciences, a Nasdaq-listed Solana treasury company, announced the issuance of 640,924 common shares to the public at $4.40 per share, raising a total of approximately $3 million in capital. Foresight News Previously, clinical-stage pharmaceutical company Artelo Biosciences (NASDAQ: ARTL) announced the completion of an over-the-counter private equity financing of $9.475 million, which will be used to launch a digital asset reserve strategy with Solana (SOL) as its core. The company became the first listed pharmaceutical company to include SOL in reserve assets.